Overview
FTRE market data
Price History
FTRE price chart · 1M
- O
- 19.76
- H
- 19.79
- L
- 19.14
- C
- 19.41
- Vol
- 102,256.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $19.76
- Previous Close
- $19.98
- Day High
- $19.79
- Day Low
- $19.14
- 52 Week High
- $21.37
- 52 Week Low
- $14.92
- 7 Day Return
- -3.02%
- 30 Day Return
- +9.63%
- 90 Day Return
- +8.68%
- 1 Year Return
- +12.69%
- Daily Notional Volume
- $2M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$10.81 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.94 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -3.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $8.31 – $21.39 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.9B · P/B 2.83 · P/S 0.70.
Company News
10 captured
8-K filing — Fortrea Holdings Inc. (FTRE)SEC EDGAR ·
UBS Initiates Coverage On Fortrea Holdings with Neutral Rating, Announces Price Target of $22Benzinga ·
Fortrea, Worldwide Clinical Trials의 임상약리 유닛·생물분석 연구소 사업 인수Globenewswire Inc ·
Fortrea 將收購 Worldwide Clinical Trials 的臨床藥理學部門及生物分析實驗室業務Globenewswire Inc ·
Fortrea Akan Mengambil Alih Unit Farmakologi Klinikal dan Operasi Makmal Bioanalisis daripada Worldwide Clinical TrialsGlobenewswire Inc ·
Fortrea Adquire Unidade de Farmacologia Clínica e Operações de Laboratório Bioanalítico da Worldwide Clinical TrialsGlobenewswire Inc ·
フォートリア、ワールドワイド・クリニカル・トライアルズから臨床薬理部門およびバイオアナリシスラボ事業を買収Globenewswire Inc ·